Umuthi 'I-Pyrogenal'. Imiyalo yokusetshenziswa

Amakhandlela "I-pyrogenal" ibhekisela kuma-immunomodulators ezinhlobonhlobo zemiphumela. Isidakamizwa sitholakala ngesimo sesisombululo somjovo. Isidakamizwa sinamandla okusebenzisa i-reticuloendothelial (izicubu ezixhunyiwe), uhlelo lwe-hypothalamic-pituitary ne-fibrinolytic (plasmin). Ukufanisa lesi sidakamizwa "I-Pyrogenal", imiyalo yokusetshenziswa ikhombisa izindawo zayo zokulwa nokuvuvukala nokunciphisa amandla (ukunciphisa ukuzwela). Isidakamizwa sisetshenziselwa ukwelashwa kwe-adjuvant (postoperative).

Ngenxa yokwazi ukugqugquzela amaseli ohlelweni lwesigaba se-phagocytic, i-phagocytosis, ukufihla kwe-oksijeni radicals, i-tumor necrosis factor, i-interleukin-1 ne-interferon synthesis iyasebenza.

Ngenxa yomphumela wokulungiselela "i-Pyrogenal" kuma-fibroblasts, ukuhlanganiswa kwe-collagen kuvinjelwa, ukuvuthwa kwe-fibroblasts kuphuthumayo.

Isidakamizwa sikhuthaza ukuqaliswa kwe-cortex eyingozi, kwandisa izinga lama-hormone.

Isidakamizwa esithi "I-Pyrogenal" yokusetshenziswa sincoma njengendlela yokwelashwa okungenasiphakamiso yokuqina kwesifo somzimba kanye ne-urethra, i-pathologies engapheli yesibindi. Isidakamizwa sisetshenziselwa ukuvimbela ukuvimbela imithi kanye ne-immunoprophylaxis ngokumelene nesizinda sokuphulukisa okungapheli ngemuva kwesifo segciwane noma se-bacteria esimweni esiyingozi. Imithi "I-Pyrogenal" isetshenziselwa ukugaya izifo zokubeletha , izinqubo zokuvuvukala ezinhlotsheni zesisu. Izinkomba zifaka izifo ze-venereal, zishise ukugula. Isixazululo somjovo sisetshenziswa ngaphezu kokugqugquzela izinqubo zokuvuselela (zokutakula) ezihambisana nezifo noma ukulimaza ohlelweni lwezinzwa (i-peripheral kanye nephakathi). Izilonda "Imiyalo ye-Pyrogenal" yokusetshenziswa ikhuthaza ezinye izifo ezibangelwa ukwelashwa (i-asthma ye-bronchial), i-streptoderma ehlulekayo ye-course engapheli, i-psoriasis nezinye izifo.

Ngemuva kokujola, kanye nokwanda kwezinga lokushisa (ngenxa yomphumela we-pyrogenic we-izidakamizwa), kunciphisa, bese kwanda ukwanda kwama-leukocytes. Ngaphezu kwalokho, ukuguqulwa kwezicubu, ukuvinjelwa kwegazi, kuhlanganise.

Ukungahambisani nemithi "Izimo ze-Pyrogenal" zokusetshenziswa zihlanganisa umkhuhlane omkhulu, ukukhulelwa, kanye nokubekezelelana ngabanye.

Njengoba umkhuba ubonisa, kanye nomthelela omuhle wezokwelapha, isiguli sibekezeleleke kahle. Ngokuyinhloko, lokhu kusebenza ekusetshenzisweni kwe-suppository, okungukuthi, ngaphezu kwalokho, kuyindlela elula yokulinganisa.

Amakhandlela afanele ukuphathwa kuphela kwi-rectum (rectally). Njengomthamo owodwa, i-suppository eyodwa ngosuku iphakanyiswa. Isingeniso senziwa ezinconyweni zikadokotela njalo ngosuku. Isilinganiso sokuqala esilinganisweni esisodwa singama-50 mcg. Ngosuku umthamo akufanele ube ngaphezu kuka-200 mcg. Inkambo yokwelapha ihilela ukwethulwa kwezidakamizwa eziyishumi nambili kuya kuyishumi nanhlanu.

Uma usebenzisa amakhandlela "I-Pyrogenal" njenge-monotherapy ye-immunorehabilitation kanye ne-immunoprophylaxis, isilinganiso esinconywayo singama-50-100 μg. Inkambo yokwelapha - kusuka kuma-suppositories amahlanu kuya kweyishumi.

Kuzincomo zikadokotela, ukusetshenziselwa okuhlanganisiwe kwe-suppositories kanye namajojo omuthi "I-Pyrogenal" kuvunyelwe.

Njengomthetho, ukwethulwa kwe-suppositories akuhambisani nemiphumela emibi. Kwezinye izimo, izinga lokushisa lingakhuphukela ku-37-37.6 ° C futhi kancane kancane.

Isidakamizwa esithi "i-Pyrogenal" sihambisana futhi sihlangene kahle nemithi ehlukene esetshenziselwa ukwelashwa kwezidakamizwa ezingenhla, kuthuthukisa ukusebenza kwama-chemotherapeutic agents ekuphatheni ukwelashwa okuyinkimbinkimbi.

Ngaphambi kokusebenzisa lesi sidakamizwa, kunconywa ukuba uthintane nodokotela.